Philippe Giaime

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Cholecalciferol and muscle strength in hemodialysis patients: results from the randomized VITADIAL trial.

Cholecalciferol and muscle strength in hemodialysis patients: results from the randomized VITADIAL trial.

Journal: Clinical kidney journal

Published: December 04, 2025

Mesangial sclerosing glomerulopathy following luspatercept treatment - a case report.

Mesangial sclerosing glomerulopathy following luspatercept treatment - a case report.

Journal: BMC nephrology

Published: November 24, 2025

From Uremic Toxins to Hemodialysis Access Failure: IL-8 and MCP-1 Chemokines as a Link Between Endothelial Activation and AV Access Complications.

From Uremic Toxins to Hemodialysis Access Failure: IL-8 and MCP-1 Chemokines as a Link Between Endothelial Activation and AV Access Complications.

Journal: Toxins

Published: June 13, 2025

Myostatin Exacerbates Endothelial Dysfunction Induced by Uremic Toxin Indoxyl Sulfate and Is Associated with Hemodialysis Arteriovenous Access Complications.

Myostatin Exacerbates Endothelial Dysfunction Induced by Uremic Toxin Indoxyl Sulfate and Is Associated with Hemodialysis Arteriovenous Access Complications.

Journal: Toxins

Published: January 30, 2025

Presence of specific SARS-COV2 antibodies in hemodialysis patients and their caregivers after the first wave of COVID-19.

Presence of specific SARS-COV2 antibodies in hemodialysis patients and their caregivers after the first wave of COVID-19.

Journal: Scientific reports

Published: October 18, 2021

Kidney biopsy in very elderly patients: indications, therapeutic impact and complications.

Kidney biopsy in very elderly patients: indications, therapeutic impact and complications.

Journal: BMC nephrology

Published: March 29, 2021

Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection.

Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: May 08, 2020

Haemodialysis patients with diabetes eat less than those without: A plea for a permissive diet.

Haemodialysis patients with diabetes eat less than those without: A plea for a permissive diet.

Journal: Nephrology (Carlton, Vic.)

Published: June 07, 2016

The "Dose-Effect" Relationship Between 25-Hydroxyvitamin D and Muscle Strength in Hemodialysis Patients Favors a Normal Threshold of 30 ng/mL for Plasma 25-Hydroxyvitamin D.

The "Dose-Effect" Relationship Between 25-Hydroxyvitamin D and Muscle Strength in Hemodialysis Patients Favors a Normal Threshold of 30 ng/mL for Plasma 25-Hydroxyvitamin D.

Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation

Published: June 17, 2015

Remission of C3 glomerulopathy with rituximab as only immunosuppressive therapy.

Remission of C3 glomerulopathy with rituximab as only immunosuppressive therapy.

Journal: Clinical nephrology

Published: January 30, 2014

Focusing on peritoneal dialysis adequacy

Focusing on peritoneal dialysis adequacy

Journal: Nephrologie & therapeutique

Published: May 13, 2013

Fluid overload and arterial hypertension in hemodialysis patients

Fluid overload and arterial hypertension in hemodialysis patients

Journal: Nephrologie & therapeutique

Published: April 24, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026